Analytical Data
-
Gene name
hasB
- Application
-
Alternative Names
(UDP-Glc dehydrogenase)(UDP-GlcDH)(UDPGDH)
-
Species
Streptococcus pyogenes
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P0C0F4
-
Expression Region
1-402aa
-
Molecular Weight
52.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of the hasB recombinant protein is rooted in the growing interest in bacterial biosynthesis and its applications in biotechnology and medicine. hasB, a gene found in certain bacteria, encodes a key enzyme involved in the biosynthesis of mycobacterial cell wall components, specifically mycolic acids. These complex lipids play a crucial role in the pathogenicity and survival of bacteria, particularly Mycobacterium tuberculosis, the causative agent of tuberculosis. Understanding the structure and function of the hasB gene and its protein product can provide insights into the mechanisms of bacterial resistance and virulence. Additionally, the use of recombinant DNA technology to produce the hasB protein allows for detailed biochemical analysis and the potential development of new therapeutic agents or vaccines targeting mycobacterial infections. Research on the hasB recombinant protein aims to elucidate its enzymatic activity, regulatory mechanisms, and interactions with other cellular components, paving the way for innovative strategies in combating mycobacterial diseases. As such, the hasB gene and its protein serve as critical focus points in the ongoing exploration of microbial pathogenesis and the pursuit of novel antimicrobial therapies.
